Page 1

xspray PHARMA INTERIM REPORT FIRST QUARTER 2021 Xspray Pharma is a product development company that focuses on cost - efficient development of improved and generic versions of orphan drugs with high value , primarily protein kinase inhibitors ( PKIS ) . The improved versions are formulated as hybrid nanoparticles ( HyNap's ) and are patentable , stable and 100 percent amorphous solid dispersions of crystalline original substances .